Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

NZBio News Update : 27 Oct 04 Bio Views

NZBio News Update : 27 Oct 04 Bio Views

In the last week members of the Biotechnology Taskforce and NZBio's Advisory Council attended a meeting hosted by the Foundation for Research Science and Technology (FRST).

The purpose of this meeting was for the group to act as sounding board for FRST's biotechnology-related draft portfolio strategies. The Foundation outlined their biotech portfolios, which include Niche Biological Products, New Zealand Strengths, Future Human Technologies, TechNZ, Pre-Seed, Production, Quality & Assurance (PQA), and Sustainable Productive Systems.

A discussion document describing the outcomes FRST is looking to achieve has been posted at: http://www.frst.govt.nz/research

While there was general agreement with the direction of strategic portfolios, the group re-iterated that a target of $300M investment in biotech R&D is necessary if we are to achieve sufficient critical mass in this area, and the current level of investment of $150M p.a. is inadequate.

While basic research capabilities need to be preserved, funding must also be available for development costs, which are usually much higher. The group also emphasized the need for continuity in FRST's investments, to allow commercial outcomes to be realised.

This is an important stage in the strategy development process for FRST, and it presents an opportunity for industry members to have some influence. I would urge you to read the document and provide feedback on it before the portfolios are finalised in December.

Going forward, NZBio will play a key role in ensuring FRST has a better understanding of the biotech sector's challenges.

Brian Ward
CEO, NZBio

Ovita puts meatier lamb chops on the menu
Roche drug gets positive recommendation
EU approves biotech corn
2005 Export Awards - entries open soon
HSNO changes announced

Ovita puts meatier lamb chops on the menu
Dunedin based company Ovita has developed a DNA blood test, called catapult LoinMAXT, to identify rams with a super-loin muscle. This month Ovita has entered the final stage of turning the science int...
More...
http://www.nzbio.org/files/members/news-detail.asp?newsID=7557

Roche drug gets positive recommendation
Roche's innovative cancer drug Avastin has received a positive recommendation from the European Committee for Medicinal Products for Human Use (CHMP). The CHMP has recommended that Avastin (bevacizuma...
More...
http://www.nzbio.org/files/members/news-detail.asp?newsID=7560

EU approves biotech corn
Monsanto has welcomed the European Commission's approval for the use of its biotech corn, NK603, and its processed products as food and food ingredients.The corn is designed to be tolerant to the acti...
More...
http://www.nzbio.org/files/members/news-detail.asp?newsID=7561

2005 Export Awards - entries open soon
New Zealand exporters are being urged to step up to the mark and enter the New Zealand Trade and Enterprise 2005 Export Awards.Entry opens on November 1, 2004, and award categories include Agritech, L...
More...
http://www.nzbio.org/files/members/news-detail.asp?newsID=7562

HSNO changes announced
Changes to the Hazardous Substances and New Organisms Act 1996 (HSNO) have been given the green light, Environment Minister, Marian Hobbs said today. An amendment bill will be introduced to Parliament...
More...
http://www.nzbio.org/files/members/news-detail.asp?newsID=7563

Quote of the week: Curiosity is the key to creativity.
Akio Morita

The contents of the NZBio News Update represents a small selection of articles posted to the members-only area of our web site. We encourage members to log-in daily to take full advantage of this frequently updated service.

From the NZBio News Team

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Voluntary Administration: Renaissance Brewing Up For Sale

Renaissance Brewing, the first local company to raise capital through equity crowdfunding, is up for sale after cash flow woes and product management issues led to the appointment of voluntary administrators. More>>

Elsewhere:

Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>

ALSO:

Media Mega Merger: Full Steam Ahead For Appeal

New Zealand's two largest news publishers have confirmed they are committed to pursuing their appeal against the Commerce Commission's rejection of the proposal to merge their operations. More>>

Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>

ALSO:

Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>